Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00432783 · ClinicalTrials.gov registry record
A Comparison of Adherence Rates to Ritonavir and Its Accompanying Protease Inhibitor
A clinical trial, sponsored by Montefiore Medical Center.
- Completed
- Registry status
- 45
- Enrollment target
NCT00432783: Completed study, sponsored by Montefiore Medical Center.
NCT00432783 is a clinical trial that has completed, run by Montefiore Medical Center. The registered enrollment target is 45 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00432783 has completed, sponsored by Montefiore Medical Center.
- COMPLETED
- Registry status
- 45 participants
- Enrollment target
Study Summary
Pharmacologic boosting of protease inhibitors with ritonavir has become standard practice in antiretroviral therapy. Patients are instructed to take ritonavir at the same time as its accompanying protease inhibitor. However, ritonavir is unpopular with many patients because of its large size and because of the recommended need for refrigeration. This study will test the hypothesis that adherence to ritonavir is inferior to adherence to its accompanying protease inhibitor in patients receiving such therapy.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 45 participants |
| Start Date | 2006-06 |
| Est. Completion | 2007-08 |
What the finished NCT00432783 record still lists
NCT00432783 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 45 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT00432783 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00432783 about?
NCT00432783 is a clinical study titled "A Comparison of Adherence Rates to Ritonavir and Its Accompanying Protease Inhibitor". Pharmacologic boosting of protease inhibitors with ritonavir has become standard practice in antiretroviral therapy. Patients are instructed to take ritonavir at the same time as its accompanying protease inhibitor. However, ritonavir is unpopular with many patients because of its large size and bec...
What is the current status of trial NCT00432783?
This trial is currently completed. The enrollment target is 45 participants. The study started on 2006-06. Estimated completion is 2007-08.
Who is sponsoring clinical trial NCT00432783?
This trial is sponsored by Montefiore Medical Center, which has 345 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00804154 · 45 participants · Phase 1
Resiniferatoxin to Treat Severe Pain Associated With Advanced Cancer
- NCT01851694 · 45 participants · NA
Beta-cell Response to Incretin Hormones in Cystic Fibrosis
- NCT02896335 · 45 participants · Phase 2
Palbociclib and Pembrolizumab In Central Nervous System Metastases
- NCT03454035 · 45 participants · Phase 1
Ulixertinib/Palbociclib in Patients With Advanced Pancreatic and Other Solid Tumors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia